Nanomedicines: addressing the scientific and regulatory gap

Tinkle, Sally and McNeil, Scott E. and Mühlebach, Stefan and Bawa, Raj and Borchard, Gerrit and Barenholz, Yechezkel Chezy and Tamarkin, Lawrence and Desai, Neil. (2014) Nanomedicines: addressing the scientific and regulatory gap. Annals of the New York Academy of Sciences [0077-8923], 1313. pp. 35-56.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/72680/

Downloads: Statistics Overview


Nanomedicine is the application of nanotechnology to the discipline of medicine: the use of nanoscale materials for the diagnosis, monitoring, control, prevention, and treatment of disease. Nanomedicine holds tremendous promise to revolutionize medicine across disciplines and specialties, but this promise has yet to be fully realized. Beyond the typical complications associated with drug development, the fundamentally different and novel physical and chemical properties of some nanomaterials compared to materials on a larger scale (i.e., their bulk counterparts) can create a unique set of opportunities as well as safety concerns, which have only begun to be explored. As the research community continues to investigate nanomedicines, their efficacy, and the associated safety issues, it is critical to work to close the scientific and regulatory gaps to assure that nanomedicine drives the next generation of biomedical innovation.
Faculties and Departments:05 Faculty of Science > Departement Pharmazeutische Wissenschaften > Pharmazie > Klinische Pharmazie/Spitalpharmazie (Meier)
UniBasel Contributors:Mühlebach, Stefan F
Item Type:Article, refereed
Article Subtype:Research Article
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:20 Aug 2020 12:40
Deposited On:20 Aug 2020 12:40

Repository Staff Only: item control page